Ahmed, F., Gaul, C., Kollewe, K., Singh, R. C., & Sommer, K. Real-World Safety and Efficacy of 156 U – 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study. BMC.
Chicago Style (17th ed.) CitationAhmed, Fayyaz, Charly Gaul, Katja Kollewe, Ritu C. Singh, and Katherine Sommer. Real-World Safety and Efficacy of 156 U – 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study. BMC.
MLA (9th ed.) CitationAhmed, Fayyaz, et al. Real-World Safety and Efficacy of 156 U – 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study. BMC.
Warning: These citations may not always be 100% accurate.